Clinical trial
Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer
NCT00031876 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00031876 |
|---|---|
| Title | Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer |
| Official title | Phase I/II Trial of Capecitabine With Weekly Paclitaxel for Advanced Breast Cancer |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | capecitabine, paclitaxel |
| Enrollment | 34 |
| Start date | May 1, 2000 |
| Primary completion | Sep 1, 2004 |
| Completion | Sep 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | May 15, 2012 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: